NVR Logo
California stem cell agency fights for life in court
Tuesday, February 28, 2006
Save and Share Share
HAYWARD -- Two lawsuits trying to abolish state-funded stem cell research have "tortured interpretations of the constitution," a deputy attorney general argued Monday at the start of a trial to determine a research institute's fate.

Three taxpayer groups filed a pair of lawsuits claiming the California Institute for Regenerative Medicine is not a legitimate state agency because it lacks proper oversight.
Proposition 71, passed by 59 percent of voters in 2004, created the agency and authorized it to dole out an average of $300 million in research grants annually over 10 years.

Fifteen months later, the agency has yet to hand out a dime because legal troubles have scared off lenders who won't buy the institute's bonds until the litigation is resolved.
Scientists hope to use human embryonic stem cells, created in the first days after conception, to replace diseased tissue. But many social conservatives, including President Bush, oppose the work because human embryos are destroyed during research.

The ballot initiative was a reaction to the Bush administration's decision to cap federal stem cell research funding at about $25 million annually and to impose strict guidelines that scientists say limit advances.
"Proposition 71 has drawn intense opposition," deputy attorney general Tamar Pachter said in defense of the institute. "It bypassed state and federal legislation and it expresses the will of the voters."

The lawsuits contend the committee overseeing the agency operates outside of state control and, thus, shouldn't be publicly funded.

Elected officials appoint 22 of the 29 board members, and five are appointed by the University of California. The chairman and vice chairman are appointed by the board itself.

David Llewellyn, a lawyer representing the California Family Bioethics Council, argued in his opening that the stem cell agency is rife with conflicts of interest.

The five University of California officials who sit on the board overseeing the agency could benefit because the school's various campuses are in line to receive millions in research funds, Llewellyn said.

Llewellyn also charged that the five UC members were also instrumental in establishing policies that determine how taxpayers will share potential drug profits generated by the grants while also serving in the same capacity at the University of California.

"They have vested interests and strong positions influencing these decisions," Llewellyn said. "It's a classic conflict of interest."

Bob Klein, chairman of the institute's oversight committee, was the first witness called in the trial and immediately defended the appointment of the UC officials.

"They take an oath," Klein said. "They do no come to represent those institutions."

Llewellyn also argued that several other board members on the Independent Citizens Oversight Committee are biotechnology executives or hold significant investments in medical companies that could benefit from stem cell grants awarded by the institute.

Agency officials said outside court that Proposition 71 specifically calls for appointing university officials and biotechnology executives with scientific expertise to run the novel research agency. When direct conflicts arise, members are supposed to recuse themselves from deliberations.

Klein, a wealthy Palo Alto real estate developer who led the $30 million campaign for Proposition 71, said outside court that the plaintiff's argument is akin to barring parents with school-aged children from serving on school boards.

Pachter said such a legal challenge has been successful only twice in California's history when one such endeavor was set up to benefit the Catholic Church and the other for a private company.

"The people decided that the state of California should spend money on stem cell research," Pachter said. "State money is not being drawn other than a public purpose: funding stem cell research."

The People's Advocate and National Tax Limitation Foundation filed the other lawsuit.

Alameda County Superior Court Judge Bonnie Lewman Sabraw is hearing the trial without a jury.

In November, the judge refused to toss out the lawsuits, but said the taxpayer groups had a high legal hurdle to prove the voter-approved agency was "clearly, positively and unmistakably unconstitutional."

The Alameda County case is People's Advocate and National Tax Limitation Foundation v. Independent Citizens' Oversight Committee, HG05206766.
No comments posted.
Comment Guidelines
The goal of the story comments section at NapaValleyRegister.com is to have an open, thought-provoking, civil community forum for all issues.
What gets your comment posted?
• Staying on topic
• Keeping your comment to 300 words or less
• Avoiding name-calling
• Addressing your comments to the message rather than the messenger
What gets your comment deleted?
• Personal attacks
• Derogatory remarks
• Name-calling of any sort
• Going off-topic
• Hate speech
• Racially-insensitive comments
• Implying guilt of a subject in a crime story before there is a court verdict
• Posting e-mail addresses
• Posting comments of a commercial nature
• POSTING WITH ALL CAPITAL LETTERS
• Linking multiple comments together with "to be continued..." to get around the 300 word limit.
The fine print
- Comments are either approved or denied. We do not edit comments.
- You are welcome to modify and resubmit a denied comment.
- Comments may take several hours to be posted.
- Comments posted are those of the writer, and do not necessarily reflect the opinion of NapaValleyRegister.com, its employees or its parent company.
- Do you have information on a story? Please go to our virtual newsroom to send us a news tip.
- If you feel a posted comment has violated our guidelines, please contact online@napanews.com or add a comment indicating you have an issue and our moderators will review the comment in question.
Search:
Web Search Powered
By Yahoo! Search
Napa Valley Register on Facebook
Copyright © 2009 Napa Valley Publishing, a member of Lee Enterprises, Inc.
Terms of Use | Privacy Policy